| Maria A Johnides, OTR/L | |
|
1000 W Erie St, Albion, MI 49224-1568 | |
| (517) 629-5501 | |
| Not Available |
| Full Name | Maria A Johnides |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1000 W Erie St, Albion, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235462896 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5201007072 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria A Johnides, OTR/L 64 Danbury Rd, Wilton, CT 06897-4429 Ph: (800) 278-0332 | Maria A Johnides, OTR/L 1000 W Erie St, Albion, MI 49224-1568 Ph: (517) 629-5501 |
News Archive
Announcing a new article publication for BIO Integration journal. In this article the authors Jingdun Xie, Zhenhua Qi, Xiaolin Luo, Fang Yan, Wei Xing, Weian Zeng, Dongtai Chen and Qiang Li; from Sun Yat-sen University, Guangzhou, Guangdong, China discuss integration analysis of m6A regulators and m6A-related genes in hepatocellular carcinoma (HCC).
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have done an in-depth analysis of food safety at nonprofit food pantries that distribute food directly to people in need. While the work has identified shortcomings at many such pantries, the goal was to identify how food safety experts can help these pantries best meet the needs of their clients.
By earning "top rankings" in six out of 16 medical specialties, The Mount Sinai Hospital achieved "Honor Roll" status in this year's U.S. News & World Report "Best Hospitals" guidebook.
Routine mammograms performed for breast cancer screening could serve another purpose as well: detecting calcifications in the blood vessels of patients with advanced kidney disease, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), showing it is safe and well tolerated in patients with hospital-acquired pneumonia caused by Pseudomonas aeruginosa. The compound, a fully human IgM monoclonal antibody, has the potential to reduce mortality rates.
› Verified 9 days ago
Megan Thrum, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 B Dr N, Albion, MI 49224 Phone: 517-630-0267 |